🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Robert J. Kinders

Leidos (United States)

ORCID: 0000-0002-5310-3367

Also affiliated with Frederick National Laboratory for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Preclinical Modeling of a Phase 0 Clinical Trial: Qualification of a Pharmacodynamic Assay of Poly (ADP-Ribose) Polymerase in Tumor Biopsies of Mouse Xenografts

(2023)10.1158/1078-0432.c.6517116.v1

Top 100%

0DataRank

Top 100%0 citations

Melinda G. Hollingshead, Sonny Khin, Larry Rubinstein, Joseph E. Tomaszewski, James H. Doroshow +2 more

Papers

Driven by 15 papers — median percentile 0. Top paper: “Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas”.

Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas

Oncotarget(2020)10.18632/oncotarget.27784

N/A

0DataRank · unranked

20 citations

Shivaani Kummar, Robert Meehan, T. Khanh, Jerry M. Collins, Larry Anderson +20 more

Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors

Cancer Chemotherapy and Pharmacology(2020)10.1007/s00280-020-04073-5

N/A

0DataRank · unranked

26 citations

Lihua Wang, Jennifer Zlott, Lamin Juwara, Joseph M. Covey, Jan H. Beumer +18 more

Tumor genomic analysis for biomarker identification in a phase I trial of the Wee 1 inhibitor adavosertib (AZD1775).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3624

N/A

0DataRank · unranked

4 citations

Arjun Mittra, Geraldine O’Sullivan Coyne, Li Chen, Biswajit Das, Shivaani Kummar +15 more

Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0329

N/A

0DataRank · unranked

71 citations

Abdul Rafeh Naqash, Geraldine O’Sullivan Coyne, Shivaani Kummar, T. Khanh, Ashley Bruns +19 more

TET2 and DNMT3A mutations and exceptional response to 4′-thio-2′-deoxycytidine in human solid tumor models

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01091-5

N/A

0DataRank · unranked

12 citations

Melinda G. Hollingshead, Larry Rubinstein, Dat Nguyen, Angelo B. A. Larenjeira, Robert J. Kinders +3 more

Reproducible, high-dimensional imaging in archival human tissue by multiplexed ion beam imaging by time-of-flight (MIBI-TOF)

Laboratory Investigation(2022)10.1038/s41374-022-00778-8

N/A

0DataRank · unranked

51 citations

Marc Bossé, Alex Kong, Adam Kagel, Robert J. Kinders, Stephen M. Hewitt +6 more

Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density

Redox Biology(2022)10.1016/j.redox.2022.102529

N/A

0DataRank · unranked

24 citations

Lisa A. Ridnour, Robert Y.S. Cheng, Abigail J. Walke, Noémi Kedei, Dibyangana D. Bhattacharyya +21 more

DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors

Scientific Reports(2023)10.1038/s41598-023-32509-4

N/A

0DataRank · unranked

73 citations

Melinda G. Hollingshead, Dat Nguyen, Robert J. Kinders, James H. Doroshow, Sherry X. Yang +1 more

Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcome

Cell Death and Disease(2023)10.1038/s41419-023-05834-9

N/A

0DataRank · unranked

17 citations

Lisa A. Ridnour, Adelaide L. Wink, Ana L. González, Elise L. Femino, Helene Rittscher +20 more

NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER-Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.21.572859

N/A

0DataRank · unranked

1 citations

William F. Heinz, Robert Y.S. Cheng, Adelaide L. Wink, Noémi Kedei, Milind Pore +21 more

Data from Preclinical Modeling of a Phase 0 Clinical Trial: Qualification of a Pharmacodynamic Assay of Poly (ADP-Ribose) Polymerase in Tumor Biopsies of Mouse Xenografts

(2023)10.1158/1078-0432.c.6517116.v1

Top 100%

0DataRank

Top 100%0 citations

Melinda G. Hollingshead, Sonny Khin, Larry Rubinstein, Joseph E. Tomaszewski, James H. Doroshow +2 more

Data from Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells

(2023)10.1158/1078-0432.c.6519651

N/A

0DataRank · unranked

0 citations

Thomas D. Pfister, Ralph E. Parchment, Shivaani Kummar, Larry Rubinstein, Yvonne A. Evrard +6 more

Interferon-gamma is Quintessential for NOS2 and COX2 Expression in ER - Breast Tumors that Lead to Poor Outcome

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.06.535916

N/A

0DataRank · unranked

0 citations

Lisa A. Ridnour, Adelaide L. Wink, Ana L. González, Elise L. Femino, Helene Rittscher +20 more

Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors

JCI Insight(2024)10.1172/jci.insight.165356

N/A

0DataRank · unranked

8 citations

Robert Y.S. Cheng, Noémi Kedei, Veena Somasundaram, Dibyangana D. Bhattacharyya, Debashree Basudhar +25 more

A phase 1 study of orally administered 5-fluoro-2’-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors

Cancer Chemotherapy and Pharmacology(2025)10.1007/s00280-025-04844-y

N/A

0DataRank · unranked

1 citations

Shivaani Kummar, Larry Rubinstein, Jennifer Zlott, Geraldine O’Sullivan Coyne, Vincent Chung +17 more